SODIUM NITROPRUSSIDE
Generic: SODIUM NITROPRUSSIDE
Mylan Institutional LLCManufacturer
INTRAVENOUSRoute
SODIUM NITROPRUSSIDEActive Substance
2018-04-17Original Approval
SODIUM NITROPRUSSIDE is FDA application ANDA210763, sponsored by MYLAN LABS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
RENAL FAILURE
74 reports
2
PAIN
62 reports
3
INJURY
59 reports
4
ANXIETY
58 reports
5
UNEVALUABLE EVENT
55 reports
6
FEAR
53 reports
7
DRUG INEFFECTIVE
52 reports
8
TOXICITY TO VARIOUS AGENTS
48 reports
9
RENAL INJURY
44 reports
10
EMOTIONAL DISTRESS
43 reports